Prediction of microvascular invasion in hepatocellular carcinoma using contrast-enhanced ultrasound and deep learning

2026-07-10 · Source: Machine learning : nature.com subject feeds · Field: Health & Wellbeing — Artificial Intelligence & Machine Learning, Medical Devices & Health Technology, Clinical Care & Medical Practice · Depth: Expert, quick

Summary

MAPUSE is a deep learning model designed for the non-invasive prediction of microvascular invasion (MVI) in hepatocellular carcinoma (HCC), a critical prognostic factor typically identified only after surgery. The model was developed using 5148 contrast-enhanced ultrasound (CEUS) videos from 1716 patients across multiple centers. MAPUSE demonstrated accurate MVI prediction, achieving AUCs ranging from 0.835 to 0.978 across varying tumor sizes, contrast agents, and prospective validations. Furthermore, transcriptomic analysis revealed a link between the model's predictions and CD8+ T cell immune infiltration, which was corroborated by the model's attention maps. Clinically, patients predicted as MVI-positive by MAPUSE showed benefit from post-ablation immunotherapy, positioning the model as a valuable tool for preoperative MVI assessment and understanding the tumor immune microenvironment.

Key takeaway

For oncologists and radiologists evaluating hepatocellular carcinoma patients, integrating MAPUSE or similar deep learning models offers a crucial preoperative, non-invasive MVI assessment. This capability allows for earlier identification of MVI-positive patients who may benefit from post-ablation immunotherapy, potentially improving treatment stratification and patient outcomes. Consider adopting such AI-driven diagnostic tools to enhance clinical decision-making and personalize treatment strategies.

Key insights

MAPUSE non-invasively predicts hepatocellular carcinoma microvascular invasion using deep learning on CEUS, linking to immune infiltration.

Principles

• Deep learning enables non-invasive MVI prediction.
• CEUS data supports accurate MVI assessment.
• AI predictions can reveal immune microenvironment links.

Method

MAPUSE was trained and tested on 5148 CEUS videos from 1716 patients. It uses deep learning to analyze CEUS data for MVI prediction, with attention maps confirming links to CD8+ T cell infiltration.

In practice

• Integrate CEUS deep learning for MVI screening.
• Use MAPUSE-like models to guide immunotherapy.
• Analyze model attention for biological insights.

Topics

• Hepatocellular Carcinoma
• Microvascular Invasion
• Contrast-Enhanced Ultrasound
• Deep Learning
• Immunotherapy
• CD8+ T cells

Best for: Computer Vision Engineer, AI Scientist, Research Scientist

Related on AIssential

• Label-free multiphoton microscopy and machine learning for recognition of hepatocellular carcinoma — Label-free multiphoton microscopy combined with machine learning accurately identifies hepatocellular carcinoma.
• From Classification to Localization and Clinical Validation: Large-Scale Development of a Deep Learning System for Thoracic Disease Detection on Chest Radiographs in Thailand — A locally adapted deep learning system for CXR achieves high accuracy, cross-site generalization, and radiologist trust through simultaneous classification and localization.
• Generalizable AI predicts immunotherapy outcomes across cancers and treatments — COMPASS uses a concept bottleneck transformer to predict ICI response from transcriptomes, offering interpretable mechanistic insights.
• Reduced NEXI protocol for the quantification of human gray matter microstructure on the Connectome 2.0 scanner — Explainable AI (XAI) can optimize complex MRI protocols, reducing scan time without losing data fidelity.
• Learning from Complementary Ultrasound Representations for Liver Disease Classification — Combining complementary ultrasound representations significantly enhances NASH/NAFLD classification accuracy over B-mode alone.
• Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Guidance — HCC-STAR is a clinical-reasoning LLM that improves HCC risk stratification and treatment guidance by analyzing EMRs.

See Counsel's argued verdicts on the open AI decisions leaders are weighing →

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Machine learning : nature.com subject feeds.